# Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy

> **NCT00121888** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 60 (—)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **BEHAVIORAL:** Prolonged Exposure Therapy
- **DRUG:** Paroxetine-CR

## Key facts

- **NCT ID:** NCT00121888
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 60 (—)
- **Last updated:** 2014-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121888, "Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00121888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*